凯普生物 (300639.sz)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(凯普生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 201,359,417.85225,783,438.27183,101,224.63253,824,938.33243,993,957.74304,523,353.13302,111,598.82
 营业收入(元) 201,359,417.85225,783,438.27183,101,224.63253,824,938.33243,993,957.74304,523,353.13302,111,598.82
二、营业总成本(元) 201,780,465.14248,275,272.61228,636,430.54317,466,019.57260,716,053.02250,416,995.02269,430,605.18
 营业成本(元) 92,296,578.8198,559,625.7490,990,841.50104,242,898.28114,717,031.3695,601,662.06115,855,670.18
 研发费用(元) 19,064,127.1821,543,424.1024,295,791.9933,966,515.6331,201,009.6233,407,421.6737,746,736.63
 营业税金及附加(元) 3,748,315.582,052,474.601,798,865.863,641,376.942,824,854.601,816,496.572,042,515.44
 销售费用(元) 55,492,566.7961,725,161.8753,777,285.75120,874,859.7956,178,830.3628,784,722.1573,284,309.30
 管理费用(元) 48,419,921.5563,929,063.6555,107,550.7170,074,770.3759,244,059.7465,454,045.8958,583,144.06
 财务费用(元) -17,241,044.77465,522.652,666,094.73-15,334,401.44-3,449,732.6625,352,646.68-18,081,770.43
  其中:利息费用(元) 485,514.14419,193.72463,532.591,098,345.471,381,075.38-3,209,707.245,675,130.84
  其中:利息收入(元) 8,898,342.636,464,350.662,583,623.4117,758,120.193,988,177.7510,135,565.401,620,282.83
 资产减值损失(元) -20,205,797.13-883,427.3881,166.72-32,717,285.996,400,434.5613,353,484.552,981,387.44
 信用减值损失(元) -308,202,032.20-83,819,721.799,930,160.835,101,565.3812,243,582.01-23,236,831.2816,173,226.19
三、其他经营收益
 加:公允价值变动收益(元) -7,962.6644,320.68-36,871.746,898.28-3,339.18-2,568.60-2,825.46
 加:投资收益(元) 1,512,359.815,907,343.211,389,961.883,174,718.30-805,367.8811,646,610.87-71,911.74
  其中:对联营企业和合营企业的投资收益(元) -43,354.30142,694.94-299,959.25-174,226.2938,831.87-131,016.90-576,722.18
 资产处置收益(元) 891,731.52474,645.63317,275.21288,284.56-32,608.306,788,650.8916,201.46
 其他收益(元) 1,004,963.81949,624.092,273,680.382,597,604.901,677,900.321,730,968.518,866,768.86
四、营业利润(元) -325,427,784.14-99,819,049.90-31,579,832.63-85,189,295.812,758,506.2564,386,673.0560,643,840.39
 加:营业外收入(元) 189,970.03157,132.14674,049.5092,042.31323,648.09104,451.1067,507.02
 减:营业外支出(元) 2,322,185.86-256,214.722,589,837.22-682,933.602,972,737.492,344,225.481,737,255.08
五、利润总额(元) -327,559,999.97-99,405,703.04-33,495,620.35-84,414,319.90109,416.8562,146,898.6758,974,092.33
 减:所得税费用(元) -56,192,448.762,151,375.76-5,701,043.52-36,254,375.89-27,207,029.5619,095,681.4312,667,364.84
六、净利润(元) -271,367,551.21-101,557,078.80-27,794,576.83-48,159,944.0127,316,446.4143,051,217.2446,306,727.49
(一)按经营持续性分类
  持续经营净利润(元) -271,367,551.21-101,557,078.80-27,794,576.83-48,159,944.0127,316,446.4143,051,217.2446,306,727.49
(二)按所有权归属分类
  归属于母公司股东的净利润(元) -184,993,886.10-62,574,464.62-14,354,781.93-31,630,751.8149,260,158.2557,488,936.6965,353,876.62
  少数股东损益(元) -86,373,665.11-38,982,614.18-13,439,794.90-16,529,192.20-21,943,711.84-14,437,719.45-19,047,149.13
 扣除非经常性损益后的净利润(元) -184,538,611.62-69,686,912.09-15,959,346.23-39,470,634.0950,383,487.4042,336,049.1859,944,794.46
七、每股收益
 一、基本每股收益(元) -0.29-0.10-0.02-0.010.080.040.15
 二、稀释每股收益(元) -0.29-0.10-0.02-0.010.080.040.15
八、其他综合收益(元) -16,283,860.118,879,652.98838,659.45-2,566,468.36-4,853,900.4451,896,445.87-27,057,644.22
 归属于母公司股东的其他综合收益(元) -16,283,860.118,879,652.98838,659.45-2,566,468.36-4,853,900.4451,896,445.87-27,057,644.22
九、综合收益总额(元) -287,651,411.32-92,677,425.82-26,955,917.38-50,726,412.3722,462,545.9794,947,663.1119,249,083.27
 归属于母公司所有者的综合收益总额(元) -201,277,746.21-53,694,811.64-13,516,122.48-34,197,220.1744,406,257.81109,385,382.5638,296,232.40
 归属于少数股东的综合收益总额(元) -86,373,665.11-38,982,614.18-13,439,794.90-16,529,192.20-21,943,711.84-14,437,719.45-19,047,149.13
公告日期 2024-10-302024-08-292024-04-272024-04-242023-10-262023-08-312023-04-25
审计意见(境内) 标准无保留意见

前瞻产业研究院